← Leaderboards
Peter G Stock
University Of California San Francisco
$42,550,391
Attributed
$45,009,802
Total exposure
13
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$45,009,802 · 13
By mechanism
U01$38,358,368 · 3
T32$3,091,571 · 1
P30$2,422,075 · 3
M01$567,409 · 4
R01$317,120 · 1
R34$253,259 · 1
Top collaborators
- Minnie M Sarwal10 shared
- Henry Masur3 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Chris Freise$3,684,866
- Kirsten L Johansen$9,035,881
- Chi-Yuan Hsu$23,088,573
Others in their field
Top investigators on “Transplantation”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Mary M Horowitz · Medical College Of Wisconsin$224,924,548
- Craig B Thompson · Sloan-Kettering Inst Can Research$157,997,949
- Charles A Coltman · Southwest Oncology Group$141,983,231
- Richard L Schilsky · University Of Chicago$117,759,216
- Harold E Varmus · Sloan-Kettering Institute For Cancer Res$82,854,111
Research focus
TransplantationResearch PersonnelResponseBaseKidney TransplantationImmune ResponseHiv InfectionsFundingSafetyImmunologicsTransplant RecipientsUnited States National Institutes Of HealthViralBiologyCommunitiesPharmaceutical PreparationsImmuneKidneyClinical TrialsGrantResourcesProspectiveNatural ImmunosuppressionProtocols Documentation
Grant awards (51)
Filling a Void of Research (FAVOR) Training for Transplant Surgeons$400,331
T32 · FY2025 · AI · contact PI
Core A: Islet Production$367,092
P30 · FY2025 · DK · contact PI
Parathyroid Allotransplant for Treatment of Hypoparathyroidism$317,120
R01 · FY2025 · DK · contact PI
Filling a Void of Research (FAVOR) Training for Transplant Surgeons$331,894
T32 · FY2024 · AI · contact PI
Filling a Void of Research (FAVOR) Training for Transplant Surgeons$315,701
T32 · FY2023 · AI · contact PI
Filling a Void of Research (FAVOR) Training for Transplant Surgeons$333,694
T32 · FY2022 · AI · contact PI
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients$350,211
U01 · FY2021 · AI · contact PI
Filling a Void of Research (FAVOR) Training for Transplant Surgeons$325,400
T32 · FY2021 · AI · contact PI
Filling a Void of Research (FAVOR) Training for Transplant Surgeons$323,269
T32 · FY2020 · AI · contact PI
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients$2,764,135
U01 · FY2019 · AI · contact PI
Filling a Void of Research (FAVOR) Training for Transplant Surgeons$309,261
T32 · FY2019 · AI · contact PI
Core A Islet Production$210,964
P30 · FY2019 · DK · contact PI
Core F Regional Islet Production$200,097
P30 · FY2019 · DK · contact PI
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients$2,057,589
U01 · FY2018 · AI · contact PI
Filling a Void of Research (FAVOR) Training for Transplant Surgeons$282,065
T32 · FY2018 · AI · contact PI
Core A Islet Production$210,964
P30 · FY2018 · DK · contact PI
Core F Regional Islet Production$200,097
P30 · FY2018 · DK · contact PI
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients$2,183,234
U01 · FY2017 · AI · contact PI
Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre and Post Liver Transplant$621,488
U01 · FY2017 · AI · contact PI
Filling a Void of Research (FAVOR) Training for Transplant Surgeons$313,354
T32 · FY2017 · AI · contact PI
Core A Islet Production$210,967
P30 · FY2017 · DK · contact PI
Core F Regional Islet Production$200,096
P30 · FY2017 · DK · contact PI
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients$1,648,456
U01 · FY2016 · AI · contact PI
Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre and Post Liver Transplant$604,473
U01 · FY2016 · AI · contact PI
Core A Islet Production$210,964
P30 · FY2016 · DK · contact PI
Core F Regional Islet Production$200,097
P30 · FY2016 · DK · contact PI
Filling a Void of Research (FAVOR) Training for Transplant Surgeons$156,602
T32 · FY2016 · AI · contact PI
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients$1,670,008
U01 · FY2015 · AI · contact PI
Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre and Post Liver Transplant$601,291
U01 · FY2015 · AI · contact PI
Core A Islet Production$210,798
P30 · FY2015 · DK · contact PI
Core F Regional Islet Production$199,939
P30 · FY2015 · DK · contact PI
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients$253,259
R34 · FY2013 · AI · contact PI
Solid Organ Transplantation in HIV: Multi-Site Study$2,734,790
U01 · FY2010 · AI · contact PI
Solid Organ Transplantation in HIV: Multi-Site Study$2,581,879
U01 · FY2009 · AI · contact PI
Solid Organ Transplantation in HIV: Multi-Site Study$729,636
U01 · FY2009 · AI · contact PI
Solid Organ Transplantation in HIV: Multi-Site Study$2,908,317
U01 · FY2008 · AI · contact PI
Solid Organ Transplantation in HIV: Multi-Site Study$3,142,602
U01 · FY2007 · AI · contact PI
Solid Organ Transplantation in HIV: Multi-Site Study$3,224,231
U01 · FY2006 · AI · contact PI
Solid Organ Transplantation in HIV: Multi-Site Study$4,458,648
U01 · FY2005 · AI
SOLID ORGAN TRANSPLANTATION IN HIV: MULTI-SITE STUDY$113,874
M01 · FY2005 · RR
SOLID ORGAN TRANSPLANTATION IN PEOPLE WITH HIV INFECTION$75,917
M01 · FY2005 · RR
PREVENTION OF AUTOIMMUNE DESTRUCTION AND REJECTION OF HUMAN PANCREATIC ISLETS$43,959
M01 · FY2005 · RR
Solid Organ Transplantation in HIV: Multi-Site Study$4,159,501
U01 · FY2004 · AI
Solid Organ Transplantation in People With HIV Infection$166,676
M01 · FY2004 · RR
Prevention of Autoimmune Destruction and Rejection of Human Pancreatic Islets$17,341
M01 · FY2004 · RR
SOLID ORGAN TRANSPLANTATION IN HIV: MULTI-SITE STUDY$12,310
M01 · FY2004 · RR
Solid Organ Transplantation in HIV: Multi-Site Study$1,917,879
U01 · FY2003 · AI
CARDIOVASCULAR RISK AFTER PREDNISONE WITHDRAWAL IN KIDNEY TRANSPLANT$68,666
M01 · FY2002 · RR
CARDIOVASCULAR RISK AFTER PREDNISONE WITHDRAWAL IN KIDNEY TRANSPLANT$68,666
M01 · FY2001 · RR
CARDIOVASCULAR RISK AFTER PREDNISONE WITHDRAWAL IN KIDNEY TRANSPLANT$0
M01 · FY2001 · RR
CARDIOVASCULAR RISK AFTER PREDNISONE WITHDRAWAL IN KIDNEY TRANSPLANT$0
M01 · FY2000 · RR